Evofem Biosciences, Inc. Annual Revenues in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Evofem Biosciences, Inc. quarterly/annual Revenues history and growth rate from 2019 to 2022.
  • Evofem Biosciences, Inc. Revenues for the quarter ending October 31, 2023 was $100M, a 1470% increase year-over-year.
  • Evofem Biosciences, Inc. annual Revenues for 2022 was $16.8M, a 104% increase from 2021.
  • Evofem Biosciences, Inc. annual Revenues for 2021 was $8.24M, a 1748% increase from 2020.
  • Evofem Biosciences, Inc. annual Revenues for 2020 was $446K.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $16.8M +$8.59M +104% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-27
2021 $8.24M +$7.8M +1748% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 $446K +$446K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.